Analyst Consensus ?
ConsensusHold79 ratings
Bullish3341.8%
Neutral3139.2%
Bearish1519.0%
1 unmapped firm rating excluded from the percentages.
Tesla, Inc. · TSLA · FY2026 Q2 · Calendar Q3 2026
Tesla Q2 2026: Revenue Beats but EPS Misses 34% as Heavy Capex and Margin Pressure Weigh
Tesla delivered record Q2 volumes and grew FSD adoption to 55% of North American deliveries, beating revenue estimates by 6.9%. However, a 34% EPS miss revealed margin compression across both automotive and energy segments, compounded by warranty true-ups, tariff-related cost changes, and rising subvention costs. The market reaction was severe with a 14.5% decline on roughly 3x baseline volume, reflecting investor concern that Tesla's massive capital expenditure cycle will continue to drain free cash flow through 2026 even as management projects confidence in its AI, robotics, and energy strategy.
Reported After market closeNASDAQConsumer Cyclical
$1221.28B market cap
100quality score
Company context
Snapshot as of publicationTesla, Inc. operates globally, specializing in the creation, production, and distribution of electric vehicles, alongside comprehensive energy generation and storage solutions. Its market reach extends across the United States, China, and various other international regions. The company's operations are primarily divided into two main segments: its Automotive business and its Energy Generation and Storage division. Within its Automotive division, Tesla not only provides a range of electric cars but also generates revenue from selling automotive regulatory credits. This segment further encompasses a variety of post-sale services, including non-warranty vehicle support, sales of pre-owned vehicles, various retail products, and car insurance offerings. Customers can acquire Tesla's sedans and sport utility vehicles through direct sales, purchases of used vehicles, or via in-app upgrades often facilitated by the extensive Tesla Supercharger network.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.33
Consensus $0
EPS surprise
-34.0%
Reported versus consensus
Reported revenue
$28.24B
Consensus $26.42B
Revenue surprise
+6.9%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$309.22Previous close
$85Low
$311.8Average
$600High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 23, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 23, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Needham | Hold | Hold | Maintain | Jul 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 23, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 23, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 23, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 23, 2026 |
| GLJ Research | Sell | Sell | Maintain | Jul 21, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 14, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 14, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 13, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Jul 2, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 6, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Dec 19, 2025 |
| Stifel | Buy | Buy | Maintain | Nov 17, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 29, 2025 |
| Freedom Capital Markets | Hold | Sell | Upgrade | Oct 24, 2025 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 13, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 18, 2025 |
| China Renaissance | Hold | Buy | Downgrade | Jul 25, 2025 |
| Guggenheim | Sell | Sell | Maintain | Jul 23, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 7, 2025 |
| HSBC | Reduce | Reduce | Maintain | Jul 3, 2025 |
| Benchmark | Buy | Buy | Maintain | Jun 26, 2025 |
| Argus Research | Hold | Buy | Downgrade | Jun 9, 2025 |
| Roth MKM | Buy | Buy | Maintain | Apr 23, 2025 |
| KGI Securities | Outperform | Neutral | Upgrade | Oct 24, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Oct 8, 2024 |
| Bernstein | Underperform | Underperform | Maintain | Oct 3, 2024 |
| New Street Research | Neutral | Buy | Downgrade | Jul 24, 2024 |
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2024 |
| Daiwa Capital | Neutral | Outperform | Downgrade | Feb 6, 2024 |
| Edward Jones | Hold | Buy | Downgrade | Jan 26, 2024 |
| CFRA | Buy | Buy | Maintain | Dec 1, 2023 |
| DZ Bank | Sell | Buy | Downgrade | Jun 23, 2023 |
| Tudor Pickering | Sell | Hold | Downgrade | Apr 20, 2023 |
| Wolfe Research | Peer Perform | Peer Perform | Maintain | Apr 10, 2023 |
| Berenberg | Hold | Buy | Downgrade | Mar 8, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jan 26, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jun 24, 2022 |
| Exane BNP Paribas | Underperform | Underperform | Maintain | Nov 17, 2021 |
| New Street | Buy | Neutral | Upgrade | Mar 9, 2021 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jan 28, 2021 |
| Wunderlich | Sell | Buy | Downgrade | Sep 23, 2020 |
| Vertical Group | Sell | Sell | Maintain | Sep 23, 2020 |
| Stifel Nicolaus | Outperform | Outperform | Maintain | Sep 23, 2020 |
| Standpoint Research | Sell | Sell | Maintain | Sep 23, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Sep 23, 2020 |
| Nomura | Neutral | Neutral | Maintain | Sep 23, 2020 |
| Global Equities Research | Overweight | Overweight | Maintain | Sep 23, 2020 |
| Citi | Sell | Sell | Maintain | Sep 23, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Sep 2, 2020 |
| Macquarie | Outperform | Outperform | Maintain | Oct 8, 2018 |
| Vertical Research | Sell | Sell | Maintain | Jun 14, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Citic Securities | Buy | Buy | Maintain | Feb 13, 2018 |
| Independent Research | Hold | Hold | Maintain | May 30, 2017 |
| Pacific Crest | Sector Weight | Maintain | Jun 22, 2016 | |
| Sterne Agee CRT | Buy | Buy | Maintain | Jun 2, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Mar 25, 2015 |
| Ascendiant Capital | Buy | Buy | Maintain | Oct 30, 2014 |
| MLV & Co. | Buy | Buy | Maintain | Oct 17, 2014 |
| Tigress Financial | Neutral | Neutral | Maintain | Oct 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Sep 16, 2014 |
| FBN Securities | Outperform | Outperform | Maintain | Sep 8, 2014 |
| S&P Capital IQ | Hold | Sell | Upgrade | May 7, 2014 |
| FBR Capital | Perform | Market Perform | Maintain | Feb 19, 2014 |
| Lazard | Neutral | Buy | Downgrade | Aug 12, 2013 |
| Dougherty & Co. | Buy | Buy | Maintain | Jul 17, 2013 |
| Dougherty | Buy | Buy | Maintain | Jul 17, 2013 |
| Northland Securities | Outperform | Outperform | Maintain | Mar 1, 2013 |
| Wunderlich Securities | Sell | Buy | Downgrade | Jul 18, 2012 |
| Maxim Group | Buy | Buy | Maintain | May 22, 2012 |
| Oxen Group | Buy | Buy | Maintain | Feb 17, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $309.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $420 | $308.5 | +35.8% | Jul 27, 2026 |
| Robert W. Baird | Ben Kallo | $475 | $313.03 | +53.6% | Jul 27, 2026 |
| Piper Sandler | Alexander Potter | $450 | $319.69 | +45.5% | Jul 24, 2026 |
| UBS | Analyst unavailable | $385 | $322.5 | +24.5% | Jul 23, 2026 |
| Mizuho Securities | Analyst unavailable | $450 | $327.84 | +45.5% | Jul 23, 2026 |
| Truist Financial | Analyst unavailable | $370 | $374.01 | +19.7% | Jul 23, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $485 | $374.01 | +56.8% | Jul 23, 2026 |
| Canaccord Genuity | George Gianarikas | $410 | $374.01 | +32.6% | Jul 23, 2026 |
| UBS | Analyst unavailable | $460 | $374.01 | +48.8% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $417 | $394.76 | +34.9% | Jul 14, 2026 |
| Jefferies | Analyst unavailable | $400 | $407.76 | +29.4% | Jul 13, 2026 |
| UBS | Analyst unavailable | $442 | $394.81 | +42.9% | Jul 9, 2026 |
| UBS | Analyst unavailable | $500 | $419.77 | +61.7% | Jul 7, 2026 |
| Truist Financial | William Stein | $430 | $390.94 | +39.1% | Jul 2, 2026 |
| UBS | Joseph Spak | $364 | $374.73 | +17.7% | Apr 23, 2026 |
| UBS | Analyst unavailable | $475 | $373.33 | +53.6% | Apr 23, 2026 |
| Canaccord Genuity | Analyst unavailable | $450 | $387.51 | +45.5% | Apr 23, 2026 |
| Deutsche Bank | Analyst unavailable | $465 | $345.62 | +50.4% | Apr 9, 2026 |
| Truist Financial | Analyst unavailable | $400 | $360 | +29.4% | Apr 2, 2026 |
| Canaccord Genuity | Analyst unavailable | $420 | $355.28 | +35.8% | Mar 30, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $508 | $420.42 | +64.3% | Jan 29, 2026 |
| Truist Financial | Analyst unavailable | $438 | $417.49 | +41.6% | Jan 29, 2026 |
| UBS | Joseph Spak | $352 | $418.17 | +13.8% | Jan 29, 2026 |
| Canaccord Genuity | George Gianarikas | $520 | $431.46 | +68.2% | Jan 29, 2026 |
| Morgan Stanley | Andrew Percoco | $415 | $431.46 | +34.2% | Jan 29, 2026 |
| Mizuho Securities | Vijay Rakesh | $540 | $431.46 | +74.6% | Jan 29, 2026 |
| Goldman Sachs | Analyst unavailable | $405 | $431.46 | +31.0% | Jan 29, 2026 |
| Barclays | Dan Levy | $360 | $449.36 | +16.4% | Jan 23, 2026 |
| Piper Sandler | Alexander Potter | $500 | $434.17 | +61.7% | Jan 8, 2026 |
| Truist Financial | William Stein | $439 | $442.39 | +42.0% | Jan 2, 2026 |
| Robert W. Baird | Ben Kallo | $548 | $459.64 | +77.2% | Dec 30, 2025 |
| UBS | Analyst unavailable | $551 | $488.73 | +78.2% | Dec 23, 2025 |
| Truist Financial | William Stein | $444 | $483.37 | +43.6% | Dec 19, 2025 |
| Mizuho Securities | Analyst unavailable | $530 | $475.12 | +71.4% | Dec 16, 2025 |
| Morgan Stanley | Andrew Percoco | $425 | $455 | +37.4% | Dec 7, 2025 |
| Mizuho Securities | Vijay Rakesh | $475 | $417.78 | +53.6% | Nov 25, 2025 |
| RBC Capital | Analyst unavailable | $500 | $426.49 | +61.7% | Oct 23, 2025 |
| Roth Capital | Analyst unavailable | $505 | $438.97 | +63.3% | Oct 23, 2025 |
| Truist Financial | William Stein | $406 | $422.55 | +31.3% | Oct 23, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $510 | $438.97 | +64.9% | Oct 23, 2025 |
| Canaccord Genuity | Analyst unavailable | $482 | $438.97 | +55.9% | Oct 23, 2025 |
| Cantor Fitzgerald | Andres Sheppard | $335 | $447.43 | +8.3% | Oct 21, 2025 |
| Barclays | Dan Levy | $350 | $435.15 | +13.2% | Oct 16, 2025 |
| Industrial Alliance Securities | Analyst unavailable | $300 | $428.23 | -3.0% | Oct 13, 2025 |
| Melius Research | Analyst unavailable | $520 | $413.49 | +68.2% | Oct 13, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $483 | $433.09 | +56.2% | Oct 8, 2025 |
| UBS | Joseph Spak | $247 | $447.3 | -20.1% | Oct 6, 2025 |
| Deutsche Bank | Edison Yu | $435 | $427.96 | +40.7% | Sep 26, 2025 |
| Wedbush | Daniel Ives | $600 | $425.37 | +94.0% | Sep 26, 2025 |
| Goldman Sachs | Analyst unavailable | $395 | $416.85 | +27.7% | Sep 18, 2025 |
| Morgan Stanley | Adam Jonas | $410 | $350.84 | +32.6% | Sep 5, 2025 |
| Stifel Nicolaus | Analyst unavailable | $440 | $350.84 | +42.3% | Sep 5, 2025 |
| Cantor Fitzgerald | Andres Sheppard | $355 | $329.22 | +14.8% | Jul 21, 2025 |
| UBS | Mark Delaney | $290 | $317.66 | -6.2% | Jun 30, 2025 |
| Wedbush | Dan Ives | $500 | $332.05 | +61.7% | Jun 5, 2025 |
| Mizuho Securities | Vijay Rakesh | $390 | $349.98 | +26.1% | May 16, 2025 |
| Piper Sandler | Alexander Potter | $400 | $275.35 | +29.4% | May 6, 2025 |
| Argus Research | William Selesky | $410 | $253.39 | +32.6% | Apr 24, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $450 | $250.74 | +45.5% | Apr 24, 2025 |
| Truist Financial | William Stein | $280 | $237.97 | -9.4% | Apr 22, 2025 |
| Morgan Stanley | Adam Jonas | $430 | $237.97 | +39.1% | Apr 22, 2025 |
| BNP Paribas | Stuart Pearson | $137 | $241.55 | -55.7% | Apr 16, 2025 |
| Deutsche Bank | Analyst unavailable | $345 | $263.55 | +11.6% | Mar 28, 2025 |
| Mizuho Securities | Analyst unavailable | $430 | $238.01 | +39.1% | Mar 17, 2025 |
| Robert W. Baird | Analyst unavailable | $370 | $263.45 | +19.7% | Mar 6, 2025 |
| Wedbush | Analyst unavailable | $302.8 | $302.8 | -2.1% | Feb 26, 2025 |
| Wedbush | Dan Ives | $328.5 | $328.5 | +6.2% | Feb 12, 2025 |
| Wedbush | Dan Ives | $550 | $415.11 | +77.9% | Jan 23, 2025 |
| Evercore ISI | Chris McNally | $275 | $394 | -11.1% | Jan 3, 2025 |
| Canaccord Genuity | George Gianarikas | $404 | $394 | +30.7% | Jan 3, 2025 |
| Wedbush | Daniel Ives | $515 | $400.99 | +66.5% | Dec 16, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $411 | $345.16 | +32.9% | Dec 2, 2024 |
| Wedbush | Daniel Ives | $400 | $332.89 | +29.4% | Nov 29, 2024 |
| Barclays | Dan Levy | $270 | $200 | -12.7% | Nov 18, 2024 |
| RBC Capital | Tom Narayan | $313 | $311.18 | +1.2% | Nov 15, 2024 |
| Piper Sandler | Alexander Potter | $315 | $259.86 | +1.9% | Oct 29, 2024 |
| Canaccord Genuity | George Gianarikas | $298 | $269.13 | -3.6% | Oct 28, 2024 |
| Truist Financial | William Stein | $238 | $213.65 | -23.0% | Oct 24, 2024 |
| Cantor Fitzgerald | Andres Sheppard | $255 | $213.65 | -17.5% | Oct 24, 2024 |
| KGI Securities | Terry Lee | $276 | $249.4 | -10.7% | Oct 24, 2024 |
| Goldman Sachs | Mark Delaney | $250 | $213.65 | -19.2% | Oct 24, 2024 |
| RBC Capital | Tom Narayan | $249 | $213.65 | -19.5% | Oct 24, 2024 |
| Canaccord Genuity | George Gianarikas | $278 | $213.65 | -10.1% | Oct 24, 2024 |
| Truist Financial | William Stein | $236 | $213.45 | -23.7% | Oct 23, 2024 |
| Jefferies | Philippe Houchois | $195 | $218.85 | -36.9% | Oct 21, 2024 |
| Mizuho Securities | Vijay Rakesh | $230 | $219.16 | -25.6% | Oct 14, 2024 |
| Evercore ISI | Chris McNally | $195 | $217.8 | -36.9% | Oct 14, 2024 |
| Bank of America Securities | Justin Post | $88 | $217.8 | -71.5% | Oct 11, 2024 |
| RBC Capital | Tom Narayan | $236 | $240.83 | -23.7% | Oct 8, 2024 |
| Cantor Fitzgerald | Andres Sheppard | $245 | $241.57 | -20.8% | Oct 7, 2024 |
| HSBC | Michael Tyndall | $124 | $238.31 | -59.9% | Oct 3, 2024 |
| Piper Sandler | Alexander Potter | $310 | $254.27 | +0.3% | Sep 24, 2024 |
| Bank of America Securities | John Murphy | $255 | $237.53 | -17.5% | Sep 20, 2024 |
| Canaccord Genuity | George Gianarikas | $254 | $229.81 | -17.9% | Sep 13, 2024 |
| Deutsche Bank | Ed Yu | $295 | $216.27 | -4.6% | Sep 9, 2024 |
| Barclays | Dan Levy | $220 | $230.17 | -28.9% | Sep 5, 2024 |
| Wells Fargo | Aaron Rakers | $150 | $221.71 | -51.5% | Aug 19, 2024 |
| RBC Capital | Tom Narayan | $224 | $191.76 | -27.6% | Aug 8, 2024 |
| Truist Financial | William Stein | $215 | $232.1 | -30.5% | Jul 29, 2024 |
| Argus Research | Bill Selesky | $286 | $219.8 | -7.5% | Jul 26, 2024 |
| Guggenheim | Ronald Jewsikow | $134 | $220.57 | -56.7% | Jul 24, 2024 |
| New Street | Pierre Ferragu | $225 | $246.38 | -27.2% | Jul 24, 2024 |
| UBS | Joseph Spak | $197 | $246.38 | -36.3% | Jul 24, 2024 |
| Citigroup | Itay Michaeli | $258 | $246.38 | -16.6% | Jul 24, 2024 |
| New Street | Pierre Ferragu | $235 | $247.32 | -24.0% | Jul 23, 2024 |
| Citigroup | Itay Michaeli | $274 | $241.03 | -11.4% | Jul 11, 2024 |
| Needham | Laura Martin | $300 | $130.98 | -3.0% | Jul 10, 2024 |
| Truist Financial | William Stein | $162 | $251.42 | -47.6% | Jul 8, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $265 | $187.35 | -14.3% | Jun 25, 2024 |
| UBS | Joseph Spak | $147 | $184.95 | -52.5% | Jun 24, 2024 |
| Morgan Stanley | Adam Jonas | $275 | $182.65 | -11.1% | Jun 21, 2024 |
| RBC Capital | Tom Narayan | $227 | $183.27 | -26.6% | Jun 20, 2024 |
| Cantor Fitzgerald | Andres Sheppard | $230 | $179.99 | -25.6% | May 2, 2024 |
| RBC Capital | Tom Narayan | $293 | $194.05 | -5.2% | Apr 29, 2024 |
| Evercore ISI | Chris McNally | $145 | $168.29 | -53.1% | Apr 29, 2024 |
| Wedbush | Daniel Ives | $275 | $168.29 | -11.1% | Apr 28, 2024 |
| Deutsche Bank | Emmanuel Rosner | $136 | $162.13 | -56.0% | Apr 25, 2024 |
| HSBC | Michael Tyndall | $120 | $161.12 | -61.2% | Apr 24, 2024 |
| Deutsche Bank | Emmanuel Rosner | $123 | $155.45 | -60.2% | Apr 18, 2024 |
| Barclays | Dan Levy | $180 | $157.11 | -41.8% | Apr 17, 2024 |
| Wells Fargo | Colin Langan | $120 | $174.6 | -61.2% | Apr 12, 2024 |
| Piper Sandler | Alexander Potter | $205 | $176.88 | -33.7% | Apr 10, 2024 |
| Jefferies | Philippe Houchois | $165 | $176.88 | -46.6% | Apr 10, 2024 |
| Goldman Sachs | Mark Delaney | $175 | $175.46 | -43.4% | Apr 9, 2024 |
| UBS | Joseph Spak | $160 | $173.77 | -48.3% | Apr 8, 2024 |
| Morgan Stanley | Adam Jonas | $310 | $168.38 | +0.3% | Apr 4, 2024 |
| Truist Financial | William Stein | $176 | $166.63 | -43.1% | Apr 3, 2024 |
| Robert W. Baird | Ben Kallo | $280 | $166.63 | -9.4% | Apr 3, 2024 |
| Deutsche Bank | Emmanuel Rosner | $189 | $166.63 | -38.9% | Apr 3, 2024 |
| HSBC | Michael Tyndall | $138 | $166.63 | -55.4% | Apr 2, 2024 |
| Barclays | Dan Levy | $225 | $166.63 | -27.2% | Apr 2, 2024 |
| RBC Capital | Tom Narayan | $290 | $165.91 | -6.2% | Apr 2, 2024 |
| HSBC | Michael Tyndall | $143 | $176.82 | -53.8% | Mar 28, 2024 |
| Deutsche Bank | Emmanuel Rosner | $200 | $179.83 | -35.3% | Mar 28, 2024 |
| Canaccord Genuity | George Gianarikas | $234 | $177.67 | -24.3% | Mar 27, 2024 |
| Bernstein | Toni Sacconaghi | $120 | $172.63 | -61.2% | Mar 26, 2024 |
| Mizuho Securities | Vijay Rakesh | $195 | $172.63 | -36.9% | Mar 25, 2024 |
| Goldman Sachs | Mark Delaney | $190 | $173.8 | -38.6% | Mar 18, 2024 |
| CFRA | Garrett Nelson | $275 | $163.57 | -11.1% | Mar 16, 2024 |
| UBS | Joseph Spak | $165 | $169.48 | -46.6% | Mar 13, 2024 |
| Wells Fargo | Colin Langan | $125 | $169.48 | -59.6% | Mar 13, 2024 |
| Morgan Stanley | Adam Jonas | $106.56 | $60.19 | -65.5% | Mar 5, 2024 |
| Daiwa | Jairam Nathan | $195 | $181.06 | -36.9% | Feb 6, 2024 |
| Piper Sandler | Alexander Potter | $225 | $181.72 | -27.2% | Feb 5, 2024 |
| Wedbush | Daniel Ives | $315 | $188.06 | +1.9% | Jan 31, 2024 |
| Roth Capital | Craig Irwin | $85 | $181.93 | -72.5% | Jan 25, 2024 |
| Morgan Stanley | Adam Jonas | $114.89 | $69.21 | -62.8% | Jan 24, 2024 |
| RBC Capital | Tom Narayan | $301 | $237.93 | -2.7% | Dec 1, 2023 |
| Wedbush | Dan Ives | $310 | $243.53 | +0.3% | Nov 29, 2023 |
| Morgan Stanley | Adam Jonas | $380 | $219.27 | +22.9% | Nov 7, 2023 |
| Guggenheim | Ronald Jewsikow | $125 | $219.67 | -59.6% | Oct 19, 2023 |
| Truist Financial | William Stein | $243 | $247.69 | -21.4% | Oct 3, 2023 |
| Wedbush | Daniel Ives | $350 | $249.94 | +13.2% | Sep 29, 2023 |
| Goldman Sachs | Mark Delaney | $275 | $267.11 | -11.1% | Sep 18, 2023 |
| Morgan Stanley | Adam Jonas | $400 | $248.5 | +29.4% | Sep 11, 2023 |
| Robert W. Baird | Ben Kallo | $300 | $272.64 | -3.0% | Jul 20, 2023 |
| Truist Financial | William Stein | $240 | $293.34 | -22.4% | Jul 19, 2023 |
| RBC Capital | Tom Narayan | $305 | $261.77 | -1.4% | Jun 30, 2023 |
| Goldman Sachs | Mark Delaney | $248 | $256.6 | -19.8% | Jun 26, 2023 |
| Barclays | Dan Levy | $260 | $262.27 | -15.9% | Jun 21, 2023 |
| Piper Sandler | Alex Potter | $280 | $243.93 | -9.4% | Jun 9, 2023 |
| Wedbush | Dan Ives | $300 | $234.86 | -3.0% | Jun 9, 2023 |
| Wedbush | Daniel Ives | $183 | $184.47 | -40.8% | May 26, 2023 |
| Morgan Stanley | Adam Jonas | $200 | $165.61 | -35.3% | Apr 20, 2023 |
| Barclays | Dan Levy | $230 | $187.04 | -25.6% | Apr 17, 2023 |
| Wolfe Research | Rod Lache | $185 | $174.48 | -40.2% | Mar 13, 2023 |
| Wedbush | Dan Ives | $225 | $189.82 | -27.2% | Mar 2, 2023 |
| RBC Capital | Tom Narayan | $223 | $189.88 | -27.9% | Mar 2, 2023 |
| Barclays | Dan Levy | $275 | $210.77 | -11.1% | Feb 15, 2023 |
| Morgan Stanley | Adam Jonas | $220 | $207.32 | -28.9% | Feb 10, 2023 |
| Morgan Stanley | Adam Jonas | $125 | $61.2 | -59.6% | Jan 16, 2023 |
| Deutsche Bank | Emmanuel Rosner | $125 | $60.21 | -59.6% | Jan 13, 2023 |
| Wells Fargo | Colin Langan | $130 | $123.56 | -58.0% | Jan 13, 2023 |
| Wedbush | Daniel Ives | $175 | $106.92 | -43.4% | Jan 3, 2023 |
| Goldman Sachs | Mark Delaney | $102.5 | $61.59 | -66.9% | Jan 2, 2023 |
| Canaccord Genuity | Canaccord Canaccord | $137.5 | $61.59 | -55.5% | Dec 31, 2022 |
| Robert W. Baird | Ben Kallo | $126 | $54.55 | -59.3% | Dec 28, 2022 |
| Deutsche Bank | Analyst unavailable | $135 | $69.36 | -56.3% | Dec 21, 2022 |
| Evercore ISI | Analyst unavailable | $100 | $71.06 | -67.7% | Dec 20, 2022 |
| Daiwa | Analyst unavailable | $177 | $145.83 | -42.8% | Dec 20, 2022 |
| Oppenheimer | Colin Rusch | $218 | $74.94 | -29.5% | Dec 19, 2022 |
| RBC Capital | Analyst unavailable | $225 | $156.8 | -27.2% | Dec 15, 2022 |
| Citigroup | Itay Michaeli | $176 | $156.8 | -43.1% | Dec 15, 2022 |
| Goldman Sachs | Mark Delaney | $235 | $160.95 | -24.0% | Dec 13, 2022 |
| Bernstein | Toni Sacconaghi | $150 | $182.92 | -51.5% | Nov 29, 2022 |
| Morgan Stanley | Adam Jonas | $330 | $190.95 | +6.7% | Nov 15, 2022 |
| Deutsche Bank | Emmanuel Rosner | $195 | $103.44 | -36.9% | Oct 21, 2022 |
| Morgan Stanley | Adam Jonas | $350 | $210.34 | +13.2% | Oct 20, 2022 |
| Cowen & Co. | Jeff Osborne | $205 | $207.28 | -33.7% | Oct 20, 2022 |
| J.P. Morgan | Ryan Brinkman | $150 | $207.28 | -51.5% | Oct 20, 2022 |
| RBC Capital | Joseph Spak | $325 | $207.28 | +5.1% | Oct 20, 2022 |
| UBS | Patrick Hummel | $350 | $207.28 | +13.2% | Oct 20, 2022 |
| Deutsche Bank | Emmanuel Rosner | $355 | $207.28 | +14.8% | Oct 20, 2022 |
| Deutsche Bank | Emmanuel Rosner | $355 | $207.28 | +14.8% | Oct 20, 2022 |
| Wells Fargo | Colin Langan | $230 | $222.04 | -25.6% | Oct 19, 2022 |
| Wedbush | Daniel Ives | $360 | $220.19 | +16.4% | Oct 18, 2022 |
| Wells Fargo | Colin Langan | $230 | $212.36 | -25.6% | Oct 14, 2022 |
| Truist Financial | Analyst unavailable | $348 | $246.68 | +12.5% | Oct 3, 2022 |
| Piper Sandler | Alexander Potter | $340 | $287.81 | +10.0% | Sep 29, 2022 |
| Deutsche Bank | Emmanuel Rosner Rosner | $400 | $275.33 | +29.4% | Sep 24, 2022 |
| Morgan Stanley | Adam Jonas | $383 | $308.73 | +23.9% | Sep 21, 2022 |
| Wolfe Research | Rod Lache | $360 | $270.21 | +16.4% | Sep 6, 2022 |
| Piper Sandler | Alexander Potter | $360 | $277.16 | +16.4% | Sep 1, 2022 |
| Jefferies | Analyst unavailable | $350 | $288.09 | +13.2% | Aug 26, 2022 |
| Oppenheimer | Colin Rusch | $431 | $307.4 | +39.4% | Aug 4, 2022 |
| Mizuho Securities | Vijay Rakesh | $391.67 | $306.12 | +26.7% | Aug 2, 2022 |
| Morgan Stanley | Adam Jonas | $383.33 | $272.24 | +24.0% | Jul 23, 2022 |
| Canaccord Genuity | Analyst unavailable | $271.67 | $272.5 | -12.1% | Jul 21, 2022 |
| Wells Fargo | Analyst unavailable | $276.67 | $247.5 | -10.5% | Jul 21, 2022 |
| Canaccord Genuity | George Gianarikas | $267 | $240.07 | -13.7% | Jul 18, 2022 |
| Barclays | Brian Johnson | $126.67 | $240.07 | -59.0% | Jul 17, 2022 |
| Truist Financial | William Stein | $333.33 | $240.07 | +7.8% | Jul 16, 2022 |
| CFRA | Garrett Nelson | $366.67 | $233.07 | +18.6% | Jul 12, 2022 |
| Mizuho Securities | Vijay Rakesh | $244.92 | $244.92 | -20.8% | Jun 27, 2022 |
| Morgan Stanley | Adam Jonas | $400 | $245.71 | +29.4% | Jun 26, 2022 |
| Mizuho Securities | Vijay Rakesh | $383.33 | $242.9 | +24.0% | Jun 24, 2022 |
| Credit Suisse | Dan Levy | $333.33 | $235.07 | +7.8% | Jun 24, 2022 |
| RBC Capital | Joseph Spak | $370 | $216.76 | +19.7% | Jun 20, 2022 |
| RBC Capital | Joseph Spak | $366.67 | $215.74 | +18.6% | Jun 13, 2022 |
| Barclays | Analyst unavailable | $123.33 | $239.71 | -60.1% | Jun 10, 2022 |
| Goldman Sachs | Mark Delaney | $333.33 | $234.52 | +7.8% | Jun 5, 2022 |
| Jefferies | Philippe Houchois | $350 | $253.21 | +13.2% | May 31, 2022 |
| Wedbush | Dan Inves | $333.33 | $242.66 | +7.8% | May 19, 2022 |
| Piper Sandler | Alexander Potter | $345 | $253.87 | +11.6% | May 18, 2022 |
| Wells Fargo | Colin Langan | $300 | $256.53 | -3.0% | May 15, 2022 |
| Berenberg Bank | Adrian Yanoshik | $300 | $262.37 | -3.0% | May 10, 2022 |
| Oppenheimer | Colin Rusch | $430.33 | $292.14 | +39.2% | Apr 26, 2022 |
| DNB Markets | Joseph Spak | $391.67 | $336.26 | +26.7% | Apr 21, 2022 |
| Credit Suisse | Dan Levy | $375 | $336.26 | +21.3% | Apr 21, 2022 |
| Deutsche Bank | Emmanuel Rosner | $416.67 | $336.26 | +34.7% | Apr 21, 2022 |
| Goldman Sachs | Mark Delaney | $400 | $336.26 | +29.4% | Apr 21, 2022 |
| Evercore ISI | Chris McNally | $300 | $336.26 | -3.0% | Apr 21, 2022 |
| Wells Fargo | Colin Langan | $320 | $336.26 | +3.5% | Apr 21, 2022 |
| CFRA | Garrett Nelson | $450 | $336.26 | +45.5% | Apr 21, 2022 |
| Wedbush | Daniel Ives | $466.67 | $342.72 | +50.9% | Apr 20, 2022 |
| RBC Capital | Joseph Spak | $391.67 | $325.73 | +26.7% | Apr 20, 2022 |
| Mizuho Securities | Vijay Rakesh | $433.33 | $325.73 | +40.1% | Apr 20, 2022 |
| Credit Suisse | Dan Levy | $375 | $334.76 | +21.3% | Apr 18, 2022 |
| Piper Sandler | Alexander Potter | $420 | $334.76 | +35.8% | Apr 18, 2022 |
| Deutsche Bank | Emmanuel Rosner | $400 | $381.82 | +29.4% | Apr 4, 2022 |
| UBS | Patrick Hummel | $366.67 | $381.82 | +18.6% | Apr 4, 2022 |
| Goldman Sachs | Mark Delaney | $400 | $381.82 | +29.4% | Apr 3, 2022 |
| Morgan Stanley | Adam Jonas | $433.33 | $364.66 | +40.1% | Mar 30, 2022 |
| Credit Suisse | Dan Levy | $341.67 | $366.52 | +10.5% | Mar 29, 2022 |
| Jefferies | Philippe Houchois | $416.67 | $307.05 | +34.7% | Mar 21, 2022 |
| Atlantic Equities | Trip Chowdhry | $249.5 | $134.72 | -19.3% | Feb 26, 2022 |
| Daiwa | Jairam Nathan | $300 | $269.96 | -3.0% | Feb 25, 2022 |
| Piper Sandler | Alexander Potter | $450 | $285.66 | +45.5% | Feb 19, 2022 |
| Mizuho Securities | Vijay Rakesh | $433.33 | $291.92 | +40.1% | Feb 13, 2022 |
| Canaccord Genuity | Jed Dorsheimer | $400 | $282.12 | +29.4% | Jan 29, 2022 |
| Oppenheimer | Colin Rusch | $367.67 | $276.37 | +18.9% | Jan 27, 2022 |
| New Street | Pierre Ferragu | $526.67 | $276.37 | +70.3% | Jan 27, 2022 |
| Wells Fargo | Colin Langan | $303.33 | $276.37 | -1.9% | Jan 27, 2022 |
| Robert W. Baird | Ben Kallo | $369.33 | $276.37 | +19.4% | Jan 27, 2022 |
| CFRA | Garrett Nelson | $433.33 | $312.47 | +40.1% | Jan 26, 2022 |
| Jefferies | Philippe Houchois | $466.67 | $314.63 | +50.9% | Jan 22, 2022 |
| Piper Sandler | Alexander Potter | $433.33 | $331.88 | +40.1% | Jan 19, 2022 |
| Evercore ISI | Chris McNally | $300 | $383.2 | -3.0% | Jan 4, 2022 |
| Argus Research | Bill Selesky | $437.67 | $362.82 | +41.5% | Dec 28, 2021 |
| BNP Paribas | Stuart Pearson | $260 | $363 | -15.9% | Nov 17, 2021 |
| Tudor Pickering | Matthew Portillo | $179 | $251.21 | -42.1% | Sep 23, 2021 |
Track every rating change on TSLA the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-14.5%
Event window
SPY move
-1.2%
Same window
Abnormal move
-13.3%
Stock minus SPY
Volume
3.0×
Versus trailing sessions
Subsequent drift
-3.3%
Up to 20 sessions
TSLASPY benchmark
Follow TSLA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue of $28.24B beat the $26.42B consensus estimate by 6.9%; EPS of $0.33 missed the $0.50 estimate by 34%; Record Q2 deliveries led by Model Y, now the best-selling vehicle globally; FSD attached to 55% of North American deliveries, expanding subscription revenue; Energy storage deployments grew 53% YoY, but gross margins fell on warranty true-ups and tariff changes; Stock fell approximately 14.5% in the reaction window on roughly 3x baseline volume
Guidance delta
Guidance sentiment was maintained relative to the prior quarter. Management continues to signal increasing capital expenditure with negative free cash flow expected through 2026, consistent with the prior quarter outlook. No formal guidance revision was indicated.
Key takeaways
- Record Q2 deliveries made Model Y the best-selling vehicle globally, driving a 6.9% revenue beat
- EPS of $0.33 missed estimates by 34%, reflecting margin compression in automotive and energy segments
- FSD reached 55% attach rate on North American deliveries, building recurring subscription revenue
- Robotaxi fleet operates across seven U.S. markets with 380,000 miles of unsupervised operation and zero notable incidents
- Energy storage deployments grew 53% YoY, but gross margins declined due to warranty true-ups and tariff-related cost changes
- The Terafab project signals deepening semiconductor ambitions with partners including Samsung, TSMC, and SpaceX
Management priorities
- Ramping Optimus production with a target of 10 million units per year
- Launching and detailing the Terafab project for AI chip manufacturing
- Expanding the robotaxi fleet into additional U.S. cities
- Scaling Cybercab production after accumulating chassis data
- Increasing solar panel manufacturing capacity and deploying Megapack 3
Sources
- Earnings call transcript and parsed analysis · 2026-07-23T02:04:01.771475+00:00
- FN2 earnings calendar · 2026-07-28T01:23:15.070317+00:00
- Polygon adjusted daily market bars · 2026-07-28T05:29:17.378739+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T05:29:17.375950+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.